Minimally invasive surgery for clinical T4 non-small-cell lung cancer: national trends and outcomes
European Journal of Cardio-Thoracic Surgery · 01.02.2024 · 65 (3)
DOI: 10.1093/ejcts/ezae009 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 23.01.2024. Verfasst von Jorge Humberto Rodriguez-Quintero und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Robotics. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
OBJECTIVES Recent randomized data support the perioperative benefits of minimally invasive surgery (MIS) for non-small-cell lung cancer (NSCLC). Its utility for cT4 tumours remains understudied. We, therefore, sought to analyse national trends and outcomes of minimally invasive resections for cT4 cancers. METHODS Using the 2010–2019 National Cancer Database, we identified patients with cT4N0-1 NSCLC. Patients were stratified by surgical approach. Multivariable logistic analysis was used to identify factors associated with use of a minimally invasive approach. Groups were matched using propensity score analysis to evaluate perioperative and survival end points. RESULTS The study identified 3715 patients, among whom 64.1% (n = 2381) underwent open resection and 35.9% (n = 1334) minimally invasive resection [robotic-assisted in 31.5% (n = 420); and video-assisted in 68.5% (n = 914)]. Increased MIS use was noted among patients with higher income [≥$40 227, odds ratio (OR) 1.24; 95% confidence interval (CI) 1.01–1.51] and those treated at academic hospitals (OR 1.25; 95% CI 1.07–1.45). Clinically node-positive patients (OR 0.68; 95% CI 0.55–0.83) and those who underwent neoadjuvant therapy (OR 0.78; 95% CI 0.65–0.93) were less likely to have minimally invasive resection. In matched groups, patients undergoing MIS had a shorter median length of stay (5 vs 6 days, P < 0.001) and no significant differences between 30-day readmissions or 30/90-day mortality. MIS did not compromise overall survival (log-rank P = 0.487). CONCLUSIONS Nationally, the use of minimally invasive approaches for patients with cT4N0-1M0 NSCLC has increased substantially. In these patients, MIS is safe and does not compromise perioperative outcomes or survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA.
- Division of Thoracic and Foregut Surgery, University of Rochester Medical Center, Rochester, NY, USA.
ORCID-Profile: Jorge Humberto Rodriguez-Quintero, Mohamed K Kamel, Neel P Chudgar
Förderung
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Rodriguez-Quintero, J. H., Elbahrawy, M. M., Montal, A. M., Jindani, R., Vimolratana, M., Kamel, M. K., Stiles, B. M., & Chudgar, N. P. (2024). Minimally invasive surgery for clinical T4 non-small-cell lung cancer: national trends and outcomes. European Journal of Cardio-Thoracic Surgery, 65(3). https://doi.org/10.1093/ejcts/ezae009
Vancouver
Rodriguez-Quintero JH, Elbahrawy MM, Montal AM, Jindani R, Vimolratana M, Kamel MK, et al. Minimally invasive surgery for clinical T4 non-small-cell lung cancer: national trends and outcomes. European Journal of Cardio-Thoracic Surgery. 2024;65(3). doi:10.1093/ejcts/ezae009
BibTeX
@article{RodriguezQuintero2024,
author = {Rodriguez-Quintero, Jorge Humberto and Elbahrawy, Mostafa M and Montal, Anne Michelle and Jindani, Rajika and Vimolratana, Marc and Kamel, Mohamed K and Stiles, Brendon M and Chudgar, Neel P},
title = {Minimally invasive surgery for clinical T4 non-small-cell lung cancer: national trends and outcomes},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
volume = {65},
number = {3},
doi = {10.1093/ejcts/ezae009}
}
EUVIMED